54 related articles for article (PubMed ID: 19789232)
1. Prospective Safety Study of Intrathecal Gadobutrol in Different Doses.
Sperre A; Karsrud I; Rodum AHS; Lashkarivand A; Valnes LM; Ringstad G; Eide PK
AJNR Am J Neuroradiol; 2023 May; 44(5):511-516. PubMed ID: 37024308
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy of One Molar Contrast Material in the Evaluation of Breast Lesions with MR Imaging.
Toprak N; Unal O; Avcu S
Pol J Radiol; 2015; 80():401-10. PubMed ID: 26405464
[TBL] [Abstract][Full Text] [Related]
3. Clinical Efficacy of Gadobutrol: Review of Over 25 Years of Use Exceeding 100 Million Administrations.
Endrikat J; Gutberlet M; Barkhausen J; Schöckel L; Bhatti A; Harz C; Hoffmann KT
Invest Radiol; 2024 May; 59(5):345-358. PubMed ID: 37972293
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced MR imaging.
Padhani AR
Cancer Imaging; 2000 Oct; 1(1):52-63. PubMed ID: 18194888
[No Abstract] [Full Text] [Related]
5. Cytocompatibility of pH-sensitive, chitosan-coated Fe
Zhang T; Wang L; He X; Lu H; Gao L
Front Med (Lausanne); 2022; 9():799145. PubMed ID: 35935778
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Nadarevic T; Colli A; Giljaca V; Fraquelli M; Casazza G; Manzotti C; Štimac D; Miletic D
Cochrane Database Syst Rev; 2022 May; 5(5):CD014798. PubMed ID: 35521901
[TBL] [Abstract][Full Text] [Related]
7. Polydopamine-Coated Magnetic Iron Oxide Nanoparticles: From Design to Applications.
Siciliano G; Monteduro AG; Turco A; Primiceri E; Rizzato S; Depalo N; Curri ML; Maruccio G
Nanomaterials (Basel); 2022 Mar; 12(7):. PubMed ID: 35407264
[TBL] [Abstract][Full Text] [Related]
8. How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol.
Daldrup-Link HE; Theruvath AJ; Rashidi A; Iv M; Majzner RG; Spunt SL; Goodman S; Moseley M
Pediatr Radiol; 2022 Feb; 52(2):354-366. PubMed ID: 34046709
[TBL] [Abstract][Full Text] [Related]
9. Screening of cancer predisposition syndromes.
Al-Sarhani H; Gottumukkala RV; Grasparil ADS; Tung EL; Gee MS; Greer MC
Pediatr Radiol; 2022 Feb; 52(2):401-417. PubMed ID: 33791839
[TBL] [Abstract][Full Text] [Related]
10. cRGD-Conjugated Fe
Fan X; Yuan Z; Shou C; Fan G; Wang H; Gao F; Rui Y; Xu K; Yin P
Int J Nanomedicine; 2019; 14():9631-9645. PubMed ID: 31824156
[TBL] [Abstract][Full Text] [Related]
11. Ten Things You Might Not Know about Iron Oxide Nanoparticles.
Daldrup-Link HE
Radiology; 2017 Sep; 284(3):616-629. PubMed ID: 28825888
[TBL] [Abstract][Full Text] [Related]
12. Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article.
Shin SK; Kim YS; Choi SJ; Shim YS; Jung DH; Kwon OS; Choi DJ; Kim JH
Medicine (Baltimore); 2017 Jul; 96(29):e7278. PubMed ID: 28723741
[TBL] [Abstract][Full Text] [Related]
13. 3-Aminopropylsilane-modified iron oxide nanoparticles for contrast-enhanced magnetic resonance imaging of liver lesions induced by
Demin AM; Pershina AG; Ivanov VV; Nevskaya KV; Shevelev OB; Minin AS; Byzov IV; Sazonov AE; Krasnov VP; Ogorodova LM
Int J Nanomedicine; 2016; 11():4451-4463. PubMed ID: 27660439
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of imaging for evaluation of hepatocellular carcinoma.
Murakami T; Tsurusaki M; Hyodo T; Imai Y
J Hepatocell Carcinoma; 2014; 1():101-8. PubMed ID: 27508179
[TBL] [Abstract][Full Text] [Related]
15. Description of focal liver lesions with Gd-EOB-DTPA enhanced MRI.
Caraiani CN; Dan M; Fenesan DI; Badea R
Clujul Med; 2015; 88(4):438-48. PubMed ID: 26733231
[TBL] [Abstract][Full Text] [Related]
16. Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines.
Hong TS; Bosch WR; Krishnan S; Kim TK; Mamon HJ; Shyn P; Ben-Josef E; Seong J; Haddock MG; Cheng JC; Feng MU; Stephans KL; Roberge D; Crane C; Dawson LA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):804-13. PubMed ID: 24969794
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media.
Maurea S; Mainenti PP; Tambasco A; Imbriaco M; Mollica C; Laccetti E; Camera L; Liuzzi R; Salvatore M
Quant Imaging Med Surg; 2014 Jun; 4(3):181-9. PubMed ID: 24914419
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a method for improving the detection of hepatocellular carcinoma.
Bendik E; Noël PB; Münzel D; Fingerle AA; Henninger M; Markus C; Vlassenbroek A; Rummeny EJ; Dobritz M
Eur Radiol; 2014 Jan; 24(1):250-5. PubMed ID: 23996016
[TBL] [Abstract][Full Text] [Related]
19. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging.
Heilmaier C; Lutz AM; Bolog N; Weishaupt D; Seifert B; Willmann JK
Radiology; 2009 Dec; 253(3):724-33. PubMed ID: 19789232
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
